These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 8429488
1. Hygroscopic stability and dissolution properties of spray-dried solid dispersions of furosemide with Eudragit. Otsuka M, Onoe M, Matsuda Y. J Pharm Sci; 1993 Jan; 82(1):32-8. PubMed ID: 8429488 [Abstract] [Full Text] [Related]
2. Characterization and stability of solid dispersions based on PEG/polymer blends. Bley H, Fussnegger B, Bodmeier R. Int J Pharm; 2010 May 10; 390(2):165-73. PubMed ID: 20132875 [Abstract] [Full Text] [Related]
3. Preparation and characterization of Furosemide-Eudragit controlled release systems. Aceves JM, Cruz R, Hernandez E. Int J Pharm; 2000 Feb 15; 195(1-2):45-53. PubMed ID: 10675682 [Abstract] [Full Text] [Related]
4. Physicochemical properties of direct compression tablets with spray dried and ball milled solid dispersions of tadalafil in PVP-VA. Wlodarski K, Tajber L, Sawicki W. Eur J Pharm Biopharm; 2016 Dec 15; 109():14-23. PubMed ID: 27658987 [Abstract] [Full Text] [Related]
5. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. Nielsen LH, Gordon S, Holm R, Selen A, Rades T, Müllertz A. Eur J Pharm Biopharm; 2013 Nov 15; 85(3 Pt B):942-51. PubMed ID: 24075980 [Abstract] [Full Text] [Related]
6. Amorphism and physicochemical stability of spray-dried frusemide. Matsuda Y, Otsuka M, Onoe M, Tatsumi E. J Pharm Pharmacol; 1992 Aug 15; 44(8):627-33. PubMed ID: 1359084 [Abstract] [Full Text] [Related]
12. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil. Wlodarski K, Sawicki W, Haber K, Knapik J, Wojnarowska Z, Paluch M, Lepek P, Hawelek L, Tajber L. Eur J Pharm Biopharm; 2015 Aug 15; 94():106-15. PubMed ID: 25998701 [Abstract] [Full Text] [Related]
13. The effect of drug and EUDRAGIT® S 100 miscibility in solid dispersions on the drug and polymer dissolution rate. Higashi K, Hayashi H, Yamamoto K, Moribe K. Int J Pharm; 2015 Oct 15; 494(1):9-16. PubMed ID: 26253374 [Abstract] [Full Text] [Related]
14. Crystal growth formation in melt extrudates. Bruce C, Fegely KA, Rajabi-Siahboomi AR, McGinity JW. Int J Pharm; 2007 Aug 16; 341(1-2):162-72. PubMed ID: 17524578 [Abstract] [Full Text] [Related]
15. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions. Wegiel LA, Mauer LJ, Edgar KJ, Taylor LS. J Pharm Pharmacol; 2014 Feb 16; 66(2):244-55. PubMed ID: 24433425 [Abstract] [Full Text] [Related]
16. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions. McNamara D, Yin S, Pan D, Crull G, Timmins P, Vig B. Mol Pharm; 2017 Feb 06; 14(2):377-385. PubMed ID: 28068097 [Abstract] [Full Text] [Related]
17. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier. Ghanavati R, Taheri A, Homayouni A. Mater Sci Eng C Mater Biol Appl; 2017 Mar 01; 72():501-511. PubMed ID: 28024614 [Abstract] [Full Text] [Related]
20. The effect of some acrylic polymers on dissolution of celecoxib solid dispersion formulations. Maghsoodi M, Nokhodchi A, Pourasghari Azar H. Pharm Dev Technol; 2021 Sep 01; 26(7):788-796. PubMed ID: 34159879 [Abstract] [Full Text] [Related] Page: [Next] [New Search]